☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Active Systemic JIA
Genentech Receives FDA approval for Actemra SC for the Treatment of Active Systemic JIA in patients aged ≥2 yrs.
September 14, 2018
Load more...
Back to Home